阻塞性睡眠呼吸暂停患者CPAP撤除期间的内分泌反应:两项随机对照试验数据
本研究基于两项为期2周的平行随机对照试验,评估70例接受CPAP治疗的阻塞性睡眠呼吸暂停患者撤除CPAP后神经代谢与心血管代谢标志物的变化。撤除CPAP 2周后,3,4-二羟苯甘醇、去甲肾上腺素和皮质醇升高,但肾素-血管紧张素-醛固酮系统(RAAS)各项指标未见统计学显著变化。提示CPAP撤除可能与交感神经激活的短期升高关系更密切,而非下丘脑-垂体-肾上腺轴或RAAS激活。
要点
- CPAP撤除2周后去甲肾上腺素、3,4-二羟苯甘醇和皮质醇升高。
- RAAS各项指标在CPAP撤除后未见统计学显著变化。
- CPAP撤除的短期内分泌影响以交感激活为主。
核心结论
- CPAP撤除可能与交感神经激活的短期升高关系更密切,而非下丘脑-垂体-肾上腺轴或RAAS激活。
研究设计与样本
- 两项为期2周的平行随机对照试验,共纳入70例接受CPAP治疗的阻塞性睡眠呼吸暂停患者(平均年龄61±10岁,82%为男性)。
主要发现
- CPAP撤除2周后3,4-二羟苯甘醇、去甲肾上腺素和皮质醇升高。
- 未记录到RAAS各项指标有统计学显著变化。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The aim of this investigation was to elucidate the effect of CPAP withdrawal on neurometabolic and cardiometabolic markers in patients with obstructive sleep apnoea. We evaluated 70 patients (mean age 61±10 years, 82% men) treated with CPAP in two 2-week, parallel, randomised controlled trials. CPAP withdrawal resulted in elevated 3,4-dihydroxyphenylglycol, norepinephrine and cortisol after 2 weeks of CPAP withdrawal; however, no statistically significant changes of the renin-angiotensin-aldosterone system (RAAS) determinants were documented. In summary, CPAP withdrawal may be more prominently linked to short-term increases in sympathetic activation than hypothalamic-pituitary-adrenal axis or RAAS activation. ClinicalTrials.gov Identifier: NCT02493673 and NCT02050425.
引用
- Thiel S, Haile SR, Peitzsch M, et al. Endocrine responses during CPAP withdrawal in obstructive sleep apnoea: data from two randomised controlled trials. Thorax. 2019. PMID: 31467191. doi:10.1136/thoraxjnl-2019-213522
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。